The influence of two megsin polymorphisms on the progression of IgA nephropathy.
暂无分享,去创建一个
D. Maixnerova | V. Tesar | J. Reiterová | M. Merta | J. Štekrová | H. Obeidová | O. Viklicky | R. Ryšavá
[1] P. Maxwell,et al. Association of MEGSIN 2093C-2180T haplotype at the 3' untranslated region with disease severity and progression of IgA nephropathy. , 2006, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[2] Hui Guo,et al. Family-based association study showing that immunoglobulin A nephropathy is associated with the polymorphisms 2093C and 2180T in the 3' untranslated region of the Megsin gene. , 2004, Journal of the American Society of Nephrology : JASN.
[3] G. D'Amico,et al. Natural history of idiopathic IgA nephropathy and factors predictive of disease outcome. , 2004, Seminars in nephrology.
[4] E. Tan,et al. Renin-Angiotensin System Gene Polymorphisms: Its Impact on IgAN and Its Progression to End-Stage Renal Failure among Chinese in Singapore , 2004, Nephron Physiology.
[5] S. Goto,et al. Peroxisome proliferator‐activated receptor γ C161T polymorphisms and survival of Japanese patients with immunoglobulin A nephropathy , 2003, Clinical genetics.
[6] S. Goto,et al. Angiotensinogen gene variation and renoprotective efficacy of renin-angiotensin system blockade in IgA nephropathy. , 2003, Kidney international.
[7] K. Akazawa,et al. Interaction Between ACE and ADD1 Gene Polymorphisms in the Progression of IgA Nephropathy in Japanese Patients , 2003, Hypertension.
[8] M. Nangaku,et al. Mesangial cell-predominant functional gene, megsin , 2003, Journal of Clinical and Experimental Nephrology.
[9] M. Nangaku,et al. Transcriptional regulation of a mesangium-predominant gene, megsin. , 2002, Journal of the American Society of Nephrology : JASN.
[10] K. Akazawa,et al. A(-20)C polymorphism of the angiotensinogen gene and progression of IgA nephropathy. , 2002, Kidney international.
[11] P. Finne,et al. Factors associated with progression of IgA nephropathy are related to renal function--a model for estimating risk of progression in mild disease. , 2002, Clinical nephrology.
[12] E. Bergstralh,et al. Proteinuria patterns and their association with subsequent end-stage renal disease in IgA nephropathy. , 2002, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[13] S. Goto,et al. Role of uteroglobin G38A polymorphism in the progression of IgA nephropathy in Japanese patients. , 2002, Kidney international.
[14] D. Cattran,et al. Predicting progression in IgA nephropathy. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[15] M. Nangaku,et al. Specific tissue distribution of megsin, a novel serpin, in the glomerulus and its up-regulation in IgA nephropathy. , 2001, Biochemical and biophysical research communications.
[16] J. S. Lee,et al. Uteroglobin gene polymorphisms affect the progression of immunoglobulin A nephropathy by modulating the level of uteroglobin expression. , 2001, Pharmacogenetics.
[17] T. Lehtimäki,et al. Angiotensin-Converting Enzyme Insertion/Deletion Polymorphism and Prognosis of IgA Nephropathy , 2000, Nephron.
[18] A. Busjahn,et al. Association of a uteroglobin polymorphism with rate of progression in patients with IgA nephropathy. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[19] W. Owen,et al. Evidence for genetic factors in the development and progression of IgA nephropathy. , 2000, Kidney international.
[20] M. Nangaku,et al. Expression of megsin mRNA, a novel mesangium-predominant gene, in the renal tissues of various glomerular diseases. , 1999, Journal of the American Society of Nephrology : JASN.
[21] William Arbuthnot Sir Lane,et al. Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. , 1999, Science.
[22] M. Nangaku,et al. A mesangium-predominant gene, megsin, is a new serpin upregulated in IgA nephropathy. , 1998, The Journal of clinical investigation.
[23] Y. Hiki,et al. Prognostic prediction of long‐term clinical courses in individual IgA nephropathy patients , 1997 .
[24] M. Baker,et al. Biological and clinical aspects of plasminogen activator inhibitor type 2. , 1995, Blood.
[25] F. Bachmann,et al. The Enigma PAI-2. Gene Expression, Evolutionary and Functional Aspects , 1995, Thrombosis and Haemostasis.
[26] W. Couser,et al. Role of oxidants and proteases in glomerular injury. , 1994, Kidney international.
[27] D. Lovett,et al. Proteinases and glomerular matrix turnover. , 1992, Kidney international.
[28] J. Mustonen,et al. Hypertriglyceridaemia and hyperuricaemia are risk factors for progression of IgA nephropathy. , 2000, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[29] Y. Berland,et al. Tubular lesions determine prognosis of IgA nephropathy. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[30] P. Bird. Serpins and regulation of cell death. , 1998, Results and problems in cell differentiation.
[31] R. D. McCoy,et al. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene. , 1996, Journal of Clinical Investigation.